Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Alpharma Brand of Roxithromycin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 203Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 EUROAPI
    France
    		 Handok Co., Ltd. 20050831-9-A-4-04 Roxithromycin 2005-08-31 EUROAPI France France 4 La Paterie, Vertolaye, 63480, France
    29/11/2025 Adare Pharma Solutions
    U.S.A
    		 Handok Co., Ltd. 20050831-9-A-3-03 Roxithromycin 2005-08-31 Adare Pharmaceuticals Srl Italy Via Martin Luther King, 13, 20060 Pessano in Bornago (Milan), Italy